Skip to main content

This is a list of conclusions about the brain activity (CAL) of patients being treated for RRMS (Relapsing-Remitting Multiple Sclerosis) or CIS (Clinically Isolated Syndrome). Bullet 2 - the most prominent one as it is yellow (rather than white) - states that "We found no differences in CAL patterns between the 2 treatment groups" indicating that neither treatment protocol is more effective from a cognitive functioning perspective.

Title

Conclusions about CAL in RRMS or CIS patients

Description

This is a list of conclusions about the brain activity (CAL) of patients being treated for RRMS (Relapsing-Remitting Multiple Sclerosis) or CIS (Clinically Isolated Syndrome). Bullet 2 - the most prominent one as it is yellow (rather than white) - states that "We found no differences in CAL patterns between the 2 treatment groups" indicating that neither treatment protocol is more effective from a cognitive functioning perspective.

Type

Illustration

Category

Outreach and Education

Source

https://www.industrydocuments.ucsf.edu/opioids/docs/#id=mywx0345

Date

2016

Collection

Teva and Allergan Documents

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Cite This Image

Information copied to your clipboard:

"Conclusions about CAL in RRMS or CIS patients." OIDA Image Collection. Available at https://images.oida-resources.jhu.edu/10cf036a-68ca-4e64-a4a3-e2c...